TC-110 T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TC-110 T cells, covering 2023-03-16 to 2023-03-16. Get the full timeline:
Most recent: Clinical Trial Update: TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]